Carl Langren
2019
In 2019, Carl Langren earned a total compensation of $820.5K as Chief Financial Officer at NewLink Genetics.
Compensation breakdown
| Non-Equity Incentive Plan | $163,020 |
|---|---|
| Option Awards | $234,835 |
| Salary | $368,192 |
| Other | $54,467 |
| Total | $820,514 |
Langren received $368.2K in salary, accounting for 45% of the total pay in 2019.
Langren also received $163K in non-equity incentive plan, $234.8K in option awards and $54.5K in other compensation.
Rankings
In 2019, Carl Langren's compensation ranked 10,113th out of 13,971 executives tracked by ExecPay. In other words, Langren earned more than 27.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,113 out of 13,971 | 28th |
Division Manufacturing | 4,087 out of 5,701 | 28th |
Major group Chemicals And Allied Products | 1,552 out of 2,200 | 30th |
Industry group Drugs | 1,329 out of 1,886 | 30th |
Industry Pharmaceutical Preparations | 990 out of 1,398 | 29th |
Source: SEC filing on June 23, 2020.
Langren's colleagues
We found six more compensation records of executives who worked with Carl Langren at NewLink Genetics in 2019.
2019
Charles Link
NewLink Genetics
Former Chief Executive & Scientific Officer
2019
Nicholas Vahanian
NewLink Genetics
Former President
2019
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2019
Richard Hawkins
NewLink Genetics
Chief Executive Officer
2019
Bradley Powers
NewLink Genetics
General Counsel
2019
John McKew
NewLink Genetics